Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome.

Expert Rev Clin Pharmacol 2013 Jul;6(4):387-401

Department of Research, Dendreon Corporation, 1208 Eastlake Avenue East, Seattle, WA 98109, USA.

Immunotherapies are coming to the forefront as a treatment paradigm in cancer with multiple US FDA approvals in recent years and a better understanding of their therapeutic mode of action. The control of tumor growth by the immune system is orchestrated by a complex array of cellular interactions and molecular pathways, both in the immune cells as well as the tumor. Although research over the past three decades has elucidated many aspects of tumor immunosurveillance, given the inherent complexity of the immune cell phenotypes and function, high-throughput molecular profiling ('omics') approaches have now become essential to support the discovery and development of new therapies. Technologies, such as DNA and protein microarrays, deep sequencing, mass spectrometry, as well as the computational methods for their analyses, are advancing the contributions of systems biology towards the development and mechanistic understanding of cancer immunotherapies. In this review, the authors illustrate this through some recently reported studies.

Download full-text PDF

Source
http://dx.doi.org/10.1586/17512433.2013.811814DOI Listing
July 2013
87 Reads

Publication Analysis

Top Keywords

systems biology
8
immune cell
4
cell phenotypes
4
complexity immune
4
inherent complexity
4
immunosurveillance inherent
4
phenotypes function
4
tumor immunosurveillance
4
function high-throughput
4
'omics' approaches
4
approaches essential
4
profiling 'omics'
4
molecular profiling
4
high-throughput molecular
4
aspects tumor
4
elucidated aspects
4
cellular interactions
4
interactions molecular
4
array cellular
4
complex array
4

References

(Supplied by CrossRef)
Article in Adv. Genet.
Zhu et al.
Adv. Genet. 2008
Article in Annu. Rev. Immunol.
Germain et al.
Annu. Rev. Immunol. 2011
Article in Trends Pharmacol. Sci.
Pujol et al.
Trends Pharmacol. Sci. 2010
Article in Curr. Top. Microbiol. Immunol.
Wang et al.
Curr. Top. Microbiol. Immunol. 2013
Article in Per. Med.
Naylor et al.
Per. Med. 2010
Article in Hum. Genomics
Tezak et al.
Hum. Genomics 2006

Similar Publications